Clinical Trial Update: Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study comparing 123I-MIBG and 18F-MFBG imaging in patients with newly diagnosed, high-risk neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Neuroblastoma

Drugs mentioned

• [123I]-MIBG (Iodine-123 labeled MIBG (123I-MIBG))
• [18F]-MFBG (18F-MFBG)

Snippet

Sponsor: Children's Oncology Group | Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular | Phase 2 | Status: NOT_YET_RECRUITING